» Articles » PMID: 39251995

Acute Necrotizing Encephalopathy in Adult Patients with Influenza: a Case Report and Review of the Literature

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Sep 9
PMID 39251995
Authors
Affiliations
Soon will be listed here.
Abstract

The neurological complications of influenza affect mainly the pediatric Asian population. In the category of influenza-associated encephalopathy, acute necrotizing encephalopathy (ANE) is a rapidly progressive and fulminant brain disorder associated with significant neurological sequelae and mortality. To date, only a few adult cases of influenza-associated ANE have been reported. We describe a 44-year-old woman who presented with rapid progression of consciousness impairment and recurrent generalized convulsions. Influenza was diagnosed three days prior to presentation, and infection with influenza A (H3N2) pdm09 was subsequently confirmed. A diagnosis of ANE was made based on the presence of characteristic brain MRI findings, the exclusion of central nervous system infection, and an elevated serum interleukin-6 level. Pulse steroid therapy followed by tocilizumab was initiated, which led to clinical stabilization and improvement. Genetic testing revealed that the patient carried heterozygous human leukocyte antigen DQB1 03:03 and DRB1 09:01 genotypes. An analysis of the adult cases of influenza-associated ANE in the literature and the present case revealed a wide range of ages (22-71 years), a short interval (median 3 days) between the clinical onset of influenza and ANE, and a high overall mortality rate (32%). The thalamus was the most frequent (91%) location of the lesions. Our report highlights the importance of identifying this devastating but treatable neurological complication of influenza in adults, especially those of Asian descent. As a cytokine storm is the most accepted pathogenic mechanism for ANE, cytokine-directed therapies may be promising treatments for which further investigation is warranted.

References
1.
Huang Y, Zhou B, Hong S, Cai Y . A case report and literature review on tocilizumab-cured acute necrotizing encephalopathy caused by influenza A virus. Front Pediatr. 2024; 12:1351478. PMC: 11026575. DOI: 10.3389/fped.2024.1351478. View

2.
Levine J, Ahsan N, Ho E, Santoro J . Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics. Mult Scler Relat Disord. 2020; 43:102194. PMC: 7228726. DOI: 10.1016/j.msard.2020.102194. View

3.
Abdelrahman H, Safwat A, Alsagheir M . Acute necrotizing encephalopathy in an adult as a complication of H1N1 infection. BJR Case Rep. 2020; 5(4):20190028. PMC: 6945259. DOI: 10.1259/bjrcr.20190028. View

4.
Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S . Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis. 2003; 35(1):59-61. DOI: 10.1080/0036554021000026986. View

5.
Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, Yamanaka T . Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995; 58(5):555-61. PMC: 1073485. DOI: 10.1136/jnnp.58.5.555. View